Lung Adenocarcinoma PBMC
About: Lung Adenocarcinoma PBMC - IRB-consented PBMC samples collected from donors diagnosed with Lung Adenocarcinoma. Suitable for studying immune checkpoint regulation and tumor-associated immune signatures.
Lung Adenocarcinoma PBMC
Lung Adenocarcinoma PBMC is collected from IRB-consented donors diagnosed with clinically confirmed Lung Adenocarcinoma. These peripheral blood mononuclear cell (PBMC) samples are ideal for studying immune checkpoint regulation and tumor-associated immune signatures. Cryopreserved PBMCs allow researchers to analyze T cell exhaustion, activation markers, and transcriptomic changes associated with lung adenocarcinoma and therapy resistance.
Product Features
- Cryopreserved, clinically verified lung adenocarcinoma human PBMC samples
- Cryopreserved to ensure stability and long-term storage
- Research Use Only (RUO)
De-identified Donor Data
- Clinically confirmed Lung Adenocarcinoma diagnosis
- Donor demographics: age, sex assigned at birth, ethnicity
- Medical and treatment history available when applicable
Applications
- Studying immune checkpoint regulation and tumor-associated immune signatures
- Biomarker discovery and validation
- Transcriptomic, proteomic, or functional studies
- Custom assay development and disease modeling
Compliance and Quality
- IRB-approved collection and electronic informed consent
- HIPAA-compliant donor data handling
Ordering and Customization
Lung Adenocarcinoma PBMC is available in standard and custom volumes. Contact learnmore@sanguinebio.com for international requests or documentation needs.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
PBMC
Frequently Asked Questions
1 Answer
Electronic medical records are an option to be included with the PBMC sample, as well as, flow cytometry and other phenotypic testing.
1 Answer
YES – we can often accommodate treatment-naive samples including various cancers, and you can specify immunosupression status or other requirements in the I/E criteria.
1 Answer
Self-reported infectious disease testing is always available and some of our products have additional testing.
1 Answer
HLA-typing is available for some of our PBMC products.
1 Answer
YES to both – Unique donors can be specified, and multiple vials from the same donor can be arranged. You can specify these requirements when ordering.
1 Answer
Healthy PBMCs achieve over 90% vialbity post-thaw. Although our disease-state PBMCs are processed with same stringent SOP, there is more variability depending upon disease. Learn more about our post thaw viability here. https://sanguinebio.com/pbmc-viability-quality-assurance/
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.